HLB Therapeutics Statistics

Total Valuation

KOSDAQ:115450 has a market cap or net worth of KRW 741.44 billion. The enterprise value is 751.42 billion.

Market Cap	741.44B
Enterprise Value	751.42B

Important Dates

The last earnings date was Tuesday, March 25, 2025.

Earnings Date	Mar 25, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:115450 has 83.78 million shares outstanding. The number of shares has increased by 6.36% in one year.

Current Share Class	n/a
Shares Outstanding	83.78M
Shares Change (YoY)	+6.36%
Shares Change (QoQ)	+18.95%
Owned by Insiders (%)	0.30%
Owned by Institutions (%)	5.50%
Float	73.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.34
PB Ratio	4.71
P/TBV Ratio	5.05
P/FCF Ratio	1,139.30
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-32.97
EV / Sales	13.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	1,154.64

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.13.

Current Ratio	1.70
Quick Ratio	1.46
Debt / Equity	0.13
Debt / EBITDA	49.91
Debt / FCF	35.88
Interest Coverage	-3.88

Financial Efficiency

Return on equity (ROE) is -12.97% and return on invested capital (ROIC) is -2.46%.

Return on Equity (ROE)	-12.97%
Return on Assets (ROA)	-2.27%
Return on Invested Capital (ROIC)	-2.46%
Return on Capital Employed (ROCE)	-4.06%
Revenue Per Employee	590.67M
Profits Per Employee	-245.09M
Employee Count	93
Asset Turnover	0.26
Inventory Turnover	8.40

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.95% in the last 52 weeks. The beta is -0.12, so KOSDAQ:115450's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	-35.95%
50-Day Moving Average	9,901.60
200-Day Moving Average	9,414.99
Relative Strength Index (RSI)	47.14
Average Volume (20 Days)	1,118,869

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:115450 had revenue of KRW 54.93 billion and -22.79 billion in losses. Loss per share was -275.17.

Revenue	54.93B
Gross Profit	9.98B
Operating Income	-7.62B
Pretax Income	-22.93B
Net Income	-22.79B
EBITDA	467.85M
EBIT	-7.62B
Loss Per Share	-275.17

Full Income Statement

Balance Sheet

The company has 37.77 billion in cash and 23.35 billion in debt, giving a net cash position of 14.42 billion or 172.12 per share.

Cash & Cash Equivalents	37.77B
Total Debt	23.35B
Net Cash	14.42B
Net Cash Per Share	172.12
Equity (Book Value)	181.87B
Book Value Per Share	1,880.38
Working Capital	22.22B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.29 billion and capital expenditures -636.97 million, giving a free cash flow of 650.79 million.

Operating Cash Flow	1.29B
Capital Expenditures	-636.97M
Free Cash Flow	650.79M
FCF Per Share	7.77

Full Cash Flow Statement

Margins

Gross margin is 18.17%, with operating and profit margins of -13.88% and -41.49%.

Gross Margin	18.17%
Operating Margin	-13.88%
Pretax Margin	-41.74%
Profit Margin	-41.49%
EBITDA Margin	0.85%
EBIT Margin	-13.88%
FCF Margin	1.18%

Dividends & Yields

KOSDAQ:115450 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.36%
Shareholder Yield	-6.36%
Earnings Yield	-3.07%
FCF Yield	0.09%

Stock Splits

The last stock split was on January 14, 2025. It was a forward split with a ratio of 1.05.

Last Split Date	Jan 14, 2025
Split Type	Forward
Split Ratio	1.05

Scores

KOSDAQ:115450 has an Altman Z-Score of 11.14.

Altman Z-Score	11.14
Piotroski F-Score	n/a